Comparison of prognoses in pancreatic cancer patients receiving neoadjuvant therapy versus adjuvant therapy.
| dc.contributor.author | Bozkurt, Mustafa | |
| dc.contributor.author | Dogan, Izzet | |
| dc.contributor.author | Unal, Kemal | |
| dc.contributor.author | Gural, Zeynep | |
| dc.contributor.author | Yildar, Murat | |
| dc.contributor.author | Ozil, Guzide | |
| dc.contributor.author | Yilmaz, Tonguc Utku | |
| dc.contributor.author | Ozer, Ali | |
| dc.contributor.author | Erdamar, Sibel | |
| dc.contributor.author | Arican, Ali | |
| dc.contributor.author | Caliskan, Can | |
| dc.contributor.author | Karakayali, Hamdi | |
| dc.date.accessioned | 2026-11-05T11:08:51Z | |
| dc.date.issued | 2026 | |
| dc.description.issue | 16_SUPPL | |
| dc.description.pages | e16451-e16451 | |
| dc.description.volume | 44 | |
| dc.identifier.doi | 10.1200/JCO.2026.44.16_suppl.e16451 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issn | 1527-7755 | |
| dc.identifier.uri | https://doi.org/10.1200/JCO.2026.44.16_suppl.e16451 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/11579 | |
| dc.identifier.wos | WOS:001780598500023 | |
| dc.language.iso | en | |
| dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
| dc.relation.conference | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) | |
| dc.relation.hasversion | 10.1200/JCO.2026.44.16_suppl.e16451 | |
| dc.relation.ispartof | JOURNAL OF CLINICAL ONCOLOGY | |
| dc.subject | Oncology | |
| dc.title | Comparison of prognoses in pancreatic cancer patients receiving neoadjuvant therapy versus adjuvant therapy. | |
| dc.type | Meeting Abstract | |
| oaire.citation.edition | Science Citation Index Expanded (SCI-EXPANDED) | |
| oaire.citation.edition | Conference Proceedings Citation Index - Science (CPCI-S) | |
| oaire.citation.endPage | e16451 | |
| oaire.citation.issue | 16_SUPPL | |
| oaire.citation.startPage | e16451 | |
| oaire.citation.volume | 44 | |
| person.identifier.rid | AAB-6635-2020 |
